High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025
M2 - Fri Sep 04, 8:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/7gms34/high_content) has announced the addition of the "High Content Screening (HCS) Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025" report to their offering. This report examines the High Content Screening (HCS)' market for the period 2015-2025. New product launches are resulting in product assortment and thus, increased installation of High Content Screening (HCS) instruments. This is expected to bolster growth of the High Content Screening (HCS) market over the next five to six years. Furthermore, increasing government support for research and development for drug discovery processes across the globe is expected to drive the growth of High Content Screening (HCS) market during the forecast period. Companies are focussing on penetrating untapped markets, such as Asia Pacific and Latin America, where growth of the biotechnology and biopharmaceutical industry is expected to increase significantly. The High Content Screening (HCS) market report starts with an overview of cell analysis instrumentation market. In addition, this section includes analysis of the key trends, drivers and restraints from the supply, demand and economy side, which are influencing the High Content Screening (HCS) market. Impact analysis of key growth drivers and restraints, based on the weighted average model is included in the High Content Screening (HCS) Market report to better equip and arm clients with crystal clear decision-making insights. The global High Content Screening (HCS) market is segmented on the basis of product, application, industry and regions. On the basis of product, the market is segmented as cell imaging and analysis equipment, consumables, software and services. Cell imaging and analysis equipment is further sub-segmented as High Content Screening (HCS) instruments and flow cytometers. Also, High Content Screening (HCS) instruments are categorised into high-end High Content Screening (HCS), mid-end High Content Screening(HCS) and low-end High Content Screening (HCS) instruments. A detailed analysis has been provided for every segment in terms of market size and volume analysis for High Content Screening (HCS) instruments across the globe. Key Topics Covered: 1. Research Methodology 2. Assumptions & Acronyms Used 3. Executive Summary 4. Global HCS Market Overview 5. Global HCS Market Outlook By Product 6. Global HCS Market Outlook By Application 7. Global HCS Market Outlook By Industry 8. Global HCS Market Outlook By Regions 9. Competitive Landscape 10. Key Comments by Industry Experts Companies Mentioned - Becton, Dickinson and Company - Danaher Corporation (Molecular Devices) - GE Healthcare - Merck Millipore Corporation - Olympus Corporation - PerkinElmer Inc. - Sysmex Corporation - Thermo Fisher Scientific Inc. - Thorlabs, Inc. - Yokogawa Electric Corporation For more information visit http://www.researchandmarkets.com/research/7g...gh_content
MRK: 50.95 (-0.07), DHR: 88.51 (-0.38), PKI: 48.19 (+0.31)
In Vitro Diagnostics Market 2015 Report With Forecasts to 2020
M2 - Wed Aug 19, 6:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/73hvhf/in_vitro) has announced the addition of the "In Vitro Diagnostics (IVD) Market by Product Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology) by Application (Diabetes, Cancer, Cardiology, Autoimmune Diseases) - Forecast to 2020" report to their offering. The global IVD market is estimated to reach $75.1 billion by 2020, growing at a CAGR of 5.8% during the forecast period (2015 to 2020). This market is mainly driven by the rising incidences of chronic lifestyle diseases and infectious diseases in emerging economies, rapidly aging population, and increasing adoption of point-of-care testing practices, and growing awareness of personalized medicine. In addition, extending reach of molecular diagnostics and new range of condition-specific markers and tests with advances in genomics and proteomics are creating new opportunities for this market. However, stringent regulatory framework and inadequate reimbursement are restraining the growth of this market. In 2014, North America commanded the largest share of the market, and this region is poised to dominate the market during the forecast period. However, the Asia-Pacific region is expected to be the fastest-growing regional market in the coming years. The growth in this region is attributed to the increasing investment by leading players, and respective government agencies, and increasing demand for diagnostic tests from large patient population in the region. Scope of the report This research report categorizes the global in vitro diagnostics market into the following segments: In Vitro Diagnostics Market, by Product - Instruments - Reagents and Kits - Data Management System/Software - Services In Vitro Diagnostics Market, by Technology - Clinical Chemistry - Immunochemistry/Immunoassays - Hematology - Coagulation and Hemostasis - Microbiology - Molecular Diagnostics - Other IVD Technologies In Vitro Diagnostics Market, by Application - Diabetes - Infectious Diseases - Oncology/Cancer - Cardiology - Nephrology - Autoimmune Diseases - Drug Testing - HIV/AIDS - Other Applications In Vitro Diagnostics Market, by End User - Laboratories - Hospitals - Academic Institutes - Point-of-care Testing - Patient Self-testing - Other End Users In Vitro Diagnostics Market, by Region - North America - Europe - Asia-Pacific (APAC) - Rest of the World (RoW) Key Topics Covered - Introduction - Research Methodology - Executive Summary - Premium Insights - Market Overview - Industry Insights - Global IVD Market, By Product & Service - Global IVD Market, By Technology - In Vitro Diagnostics Market, By Application - Global IVD Market, By End User - Geographic Analysis ROLA) - Competitive Landscape - Company Profiles - Appendix Companies Mentioned - Abbott Laboratories - Becton, Dickinson And Company - Bio-Rad Laboratories - Biom?rieux - Danaher Corporation - Johnson And Johnson - Ortho Clinical Diagnostics - Roche Diagnostics - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/73hvhf/in_vitro
JNJ: 95.37 (+0.29), ABT: 41.89 (+0.73), DHR: 88.51 (-0.38)
Platelet Aggregation Devices Market by Product, Application and End User - Global Forecasts to 2020
M2 - Thu Aug 13, 4:51AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bxd54q/platelet) has announced the addition of the "Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020" report to their offering. Global Platelet Aggregation Devices Market Expected to Reach a Value of 342.4 Million by 2020, Growing at a CAGR of 21.0% Growth in the platelet aggregation devices market can be attributed to factors such as rising incidence of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations & clinical studies. However, factors such as procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained & skilled professionals are restraining the growth of this market. In addition, stringent regulatory policies and limited medical reimbursements are posing significant challenges for the growth of the market. New product launches and product developments are the key strategies adopted by major players to develop their positions in the global platelet aggregation devices market. Moreover, strategies such as acquisitions & divestments; partnerships, agreements, & collaborations; and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and to expand their geographic presence in the global market. Key Topics Covered - Introduction - Research Methodology - Executive Summary - Premium Insights - Market Overview - Platelet Aggregation Devices Market, By Product - Platelet Aggregation Devices Market, By Application - Platelet Aggregation Devices Market, By End User - Platelet Aggregation Devices Market, By Region - Competitive Landscape - Company Profiles - Appendix Companies Mentioned - Accriva Diagnostics - Aggredyne, Inc. - Bio/Data Corporation - F. Hoffman-La Roche Ltd. - Haemonetics Corporation - Helena Laboratories Corporation - Sentinel Ch. S.P.A. - Siemens AG - Sysmex Corporation - TEM Group For more information visit http://www.researchandmarkets.com/research/bxd54q/platelet
HAE: 32.10 (+0.28)
D-dimer Testing Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022
M2 - Mon Jul 20, 5:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/cwrx5b/ddimer_testing) has announced the addition of the "D-dimer Testing Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2022" report to their offering. At present, the in vitro diagnostics market is one of the fastest growing markets globally. This remarkable growth can be attributed to the improved health care awareness, preference of the people for preventive health checkups, accessibility to disease specific tests, and shift from manual to semi-automated and automated instruments. Diagnostic laboratories are facing challenges in delivering high-quality, efficient and timely testing solutions due to rising health care awareness and stringent regulations that put pressure on the health care budgets. This has led to growing adoption of automated solutions and new analyzers that deliver high throughput in lesser time and with enhanced efficiency. Point-of care testing has gained momentum in the past few years to meet the demand for quick turnaround time, thus accelerating reliable results. D-dimer assays and POC kits have been developed to confirm the exclusion of deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). The D-dimer testing market has been extensively analyzed on the basis of testing methods, applications, and geography. Testing methods include point-of-care testing (POC) and laboratory testing. Laboratory testing has been further segmented into coagulation analyzers and clinical chemistry analyzers. Applications comprise deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC). Each of the segments has been analyzed in detail for market trends, number of D-dimer tests, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2014 to 2022, in terms of revenue in USD million and number of tests in million, considering 2012 and 2013 as the base years. The compound annual growth rate (%CAGR) for each market segment has been provided for the forecast period from 2014 to 2022 along with the estimations of market size. The report concludes with the company profiles section that includes key information about the major players in the market. Key players profiled in this report include Abbott Laboratories, Alere, Inc., Beckman Coulter, Inc., Bio/Data Corporation, Becton, Dickinson and Company, Corgenix, F. Hoffman-La Roche Ltd., Helena Biosciences, Siemens Healthcare, Sysmex Corporation, Thermo Fisher Scientific, and Trinity Biotech. Each of these players is profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments. Key Topics Covered: Chapter 1 Preface Chapter 2 Executive Summary Chapter 3 D-dimer Testing Market Overview Chapter 4 Global D-dimer Testing Market Revenue (USD Million) and No. of Tests (Million), by Testing Method, 2012 - 2022 Chapter 5 Global D-dimer Testing Market Revenue (USD Million) and Volume (No. of Tests in Millions), by Application, 2012 - 2022 Chapter 6 Global D-dimer Testing Market Revenue (USD Million) & Volume (No. of Tests in Millions), by Geography, 2012 - 2022 Chapter 7 Recommendations Chapter 8 Company Profiles - Abbott Laboratories, Inc. - Alere, Inc. - Beckman Coulter, Inc. - Becton, Dickinson and Company - Bio/Data Corporation - Corgenix Medical Corporation - F. Hoffmann-La Roche Ltd. - Helena Biosciences - Siemens Healthcare - Sysmex Corporation - Thermo Fisher Scientific, Inc. - Trinity Biotech plc For more information visit http://www.researchandmarkets.com/research/cw...er_testing
ABT: 41.89 (+0.73), TRIB: 12.14 (+0.18), ALR: 47.03 (-0.26)
China IVD Market and Forecast to 2020
M2 - Wed Jul 15, 8:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/87vjrd/china_ivd_market) has announced the addition of the "China IVD Market and Forecast to 2020" report to their offering. China In-Vitro Diagnostics (IVD) market is among the fastest growing in the world. It is anticipated that China IVD market will more than triple by 2020 from the 2014 level. With an aging population, a rapidly growing middle class and a government encouraging preventive care, China has the potential for more dramatic growth in the future. Further, the average Chinese consumer is now willing and able to pay more for healthcare than a decade years ago. Hence, China has the potential for more dramatic growth in the future. China IVD Market Segment Wise Analysis: Immunoassay is the leading segment in China IVD market. Immunoassay is likely to maintain its dominant position in the forecasting period as well. Clinical Chemistry holds the 2nd position in China IVD market being followed by Molecular Testing. Microbiology and Hematology market are competing closely in 2014. China IVD Market Company Analysis: In China IVD market, Roche Diagnostics is the leader in 2014. Sysmex Corporation and Mindary Medical are other top two players in the China IVD market. At present many local players are present in China IVD market. This report titled China IVD Market and Forecast to 2020 is a 86 page report with 34 Figures and 1 Table. This report studies in details the China IVD Market - Application Segment Wise, China IVD Market - Company Sales, Development Environment and Regulatory Status in China IVD market and Driving Factors and Challenges for China IVD Market. The China In Vitro Diagnostics (IVD) Market has been analyzed from 4 View Points: 1) Market and Forecast (2007 - 2020) 2) Segment Wise Market & Forecast (2007 - 2020) 3) Development Environment and Regulatory Status in China IVD market 4) Company Wise IVD Sales & Forecast (2010 - 2020) China IVD Market - 8 Application Segments Covered in the Report are: 1. Clinical Chemistry Market 2. Immunoassay Market 3. Hematology Market 4. Coagulation Market 5. Microbiology Market 6. Molecular Testing Market 7. Self Monitoring of Blood Glucose (SMBG) Market 8. Point of Care Testing (POCT) Market The Companies covered in the report are as follows: - Roche Diagnostic - Sysmex Corporation - Mindray Medical International Limited - Shanghai Kehua Bio-Engineering Co. Ltd. - Others Profiles of Private Clinical Labs and Diagnostic Services Companies in China - Zhejiang Di'an Diagnostics Technology Co., Ltd - ADICON Clinical Laboratories - Guangzhou Kingmed Diagnostics Center Co. Ltd. - Kindstar Global (Privately held) - BGI-Shenzhen (Privately held) - OriGene Technologies (Privately held) For more information visit http://www.researchandmarkets.com/research/87...ivd_market
MR: 24.13 (-0.04)
Global Immunoassay Market Forecasts and Opportunities 2015-2019 - Technology, Application, & End Users Analysis
M2 - Fri Jun 12, 6:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s48bfw/immunoassay) has announced the addition of the "Immunoassay Market by Technology, Application, & End User - Global Forecast to 2019" report to their offering. The immunoassay market is expected to reach $23,712.4 Million by 2019 from $14,926.3 Million in 2014, at a CAGR of 9.7% from 2014 to 2019 The immunoassay market is segmented on the basis of technology, products and services, applications, end users and regions. On the basis of products and services, the global immunoassay market is segmented into analyzers, reagents and kits, and software and services. The immunoassay analyzers market is further segmented based on into purchase mode reagent rental purchase and outright purchase and by type open-ended system and closed-ended system. The immunoassay reagents and kits market segment is classified into ELISA reagents, rapid tests reagents, western blot reagents, ELISPOT reagent, radioimmunoassay (RIA) reagents and PCR reagents. Based on technologies, the global immunoassay market is segmented into ELISA, rapid tests, western blot tests, enzyme-linked immunospot (ELISPOT) assay, radioimmunoassays (RIA), and PCR. The immunoassay market for ELISA testing is further categorized into first-generation, second-generation, third-generation, and fourth-generation ELISA. Based on end users, the immunoassay market is segmented into hospitals, laboratories, blood banks, academic research centers, pharmaceutical companies, CROs, and biotechnology companies, and others (physicians' offices, patient self-testing, and ambulatory centers). The global immunoassay market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the global immunoassay market in the forecast period. Over the next five years, the growth of the market in the Asian region is likely to be centered on China, India, and Japan. The key players in the immunoassay market include Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories (U.S.), Beckman Coulter (U.S.), Ortho Clinical Diagnostics (U.S.), and bioM?rieux (France). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Immunoassay Market, By Technology 8 Immunoassay Market, By Products and Services 9 Immunoassay Market, By Application 10 Immunoassay Market, By End User 11 Immunoassay Market, By Region 12 Competitive Landscape 13 Company Profiles - Abbott Laboratories, Inc. - Alere, Inc. - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton, Dickinson and Company - Bio-Rad Laboratories, Inc. - Biom?rieux SA - Ortho-Clinical Diagnostics, Inc. - Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.) - Siemens Healthcare (Subsidiary of Siemens AG) - Sysmex Corporation For more information visit http://www.researchandmarkets.com/research/s4...mmunoassay
ABT: 41.89 (+0.73), DHR: 88.51 (-0.38), ALR: 47.03 (-0.26)
Japanese Global Health Fund Welcomes the Wellcome Trust and Sysmex Corporation as New Funders and ANA, Morrison & Foerster, and Yahoo! Japan as New Sponsors
PR Newswire - Wed Jun 03, 2:01AM CDT
The Global Health Innovative Technology Fund (GHIT Fund) today welcomed partnerships with the UK's largest charitable foundation and four major global companies--collaborations that will expand continued funding for research and development (R&D) of new tools to tackle infectious diseases that devastate the world's poorest people.
Sysmex and LabCorp Announce a Strategic Collaboration for Blood-Based Molecular Testing Services and Products to Support the Development of Precision Medicine in Oncology
Business Wire - Mon Jun 01, 7:00AM CDT
Sysmex Corporation (TSE:6869) and Laboratory Corporation of America(R) Holdings (LabCorp(R)) (LH:NYSE) today announced a strategic collaboration focused on the development of blood-based molecular diagnostic tests to advance precision medicine in oncology. The collaboration combines Sysmex Inostics' strength in the development of innovative blood-based diagnostic solutions with LabCorp's unparalleled capabilities: global leadership in precision medicine through Covance Drug Development's (Covance) extensive involvement in oncology clinical trials and a unique ability to commercialize clinically-relevant diagnostic tests through LabCorp Diagnostics as such applications are developed.
LH: 112.35 (+0.64)
Coagulation Analyzer Market Expected to Reach $3.58 Billion by 2019, New Report Says
M2 - Wed May 27, 9:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/prc6rk/coagulationhemost) has announced the addition of the "Coagulation/Hemostasis Analyzer Market by Product , Consumables, Test Type, Technology, End Users - Forecast to 2019" report to their offering. The global coagulation analyzers market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. Growth in the coagulation analyzers market is driven by factors such as increasing adoption of automated hemostasis instruments by diagnostics laboratories, development of high-throughput hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers, and introduction of technologically advanced hemostasis instruments. However, slow adoption of advanced hemostasis instruments in emerging economies and high cost of hemostasis analyzers are restraining the growth of this market. New product launches and expansions are the key strategies adopted by major players to strengthen their position in the global coagulation analyzer market. Moreover, strategies such as partnerships, agreements, collaborations, joint ventures, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence. Key Topics Covered 1 Introduction 2 Research Methodology 3 Executive Summary 4 Market Overview 5 Industry Insights 6 Hemostasis/Coagulation Analyzer Market, By Product Type 6.1 Introduction 6.2 Clinical Laboratory Analyzers 6.3 Hemostasis Analyzers for Point-Of-Care Testing 7 Hemostasis/Coagulation Analyzer Market, By Type of Test 7.1 Introduction 7.2 Prothrombin Time (PT/INR) Testing Kits Market 7.3 ACTivated Clotting Time (ACT/APTT) Testing Kits Market 7.4 D Dimer Testing Kits Market 7.5 Fibrinogen Testing Kits Market 7.6 Others Testing Kits Market 8 Hemostasis/Coagulation Analyzer Market, By Technology 8.1 Introduction 8.2 Mechanical 8.3 Optical 8.4 Electrochemical 8.5 Ohers 9 Hemostasis/Coagulation Analyzer Market, By End Users 9.1 Introduction 9.2 Research Institutes 9.3 Diagnostic Laboratories 9.4 Standalone Hospitals 9.5 Other End Users 10 Coagulation Analyzer Market, By Geography 11 Competitive Landscape 12 Company Profile 13 Appendix Companies Mentioned - Alere - Diagnostica Stago - Helena Laboratories - Instrumentation Laboratory Werfen Group - International Technidyne Corporation - Nihon Kohden Corporation (Nihon Kohden) - Roche Diagnostics - Siemens Helathcare - Sysmex Corporation - Thermo Fisher Scientific For more information visit http://www.researchandmarkets.com/research/pr...tionhemost
Sysmex America, Inc. Appoints Ramon Simon-Lopez, M.D. Medical Director
PR Newswire - Wed May 13, 7:32AM CDT
Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, announces today that Ramon Simon-Lopez, M.D. has been appointed Medical Director. In his role, Dr. Simon-Lopez will be responsible for pre-market scientific and applications-based research activities for all specialties, including hematology, urinalysis, flow cytometry and hemostasis. He will work closely with Sysmex Corporation helping to increase the clinical value of Sysmex instruments.
Global Biochemical Sensors Market Forecast and Opportunities 2015-2020
M2 - Fri May 08, 9:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ctbmsf/global) has announced the addition of the "Global Biochemical Sensors Market Forecast and Opportunities, 2020" report to their offering. The global biochemical sensors market is projected to reach USD23.3 billion by 2020 Electrochemical, optical, thermal, and piezoelectric are the major types of biochemical sensors used across diverse applications. Growing health concerns, declining cost of devices coupled with miniaturization of biochemical sensing devices are few of the major factors expected to drive demand for biochemical sensors over the next five years. High accuracy, easy usability, higher sensitivity even at low analyte concentrations are boosting the adoption of biochemical sensors across diverse end use applications. Growing need for low-cost, easy to use, fast and reliable analytical tools has been paving the way for use of biochemical sensors for quantitative and qualitative determination of discrete analytes in clinical, agricultural, environmental, food and defense applications. Presently, biochemical sensors are being predominantly used in medical applications, however, their adoption is increasing in agricultural, nutritional and environmental sectors due to continuous emphasis on improving product quality and growing need to comply with legislative guidelines. Increasing research & development activities, rising government emphasis and increasing advancements in healthcare infrastructure are expected to drive the sales of biochemical sensors over next five years. Global Biochemical Sensors Market Forecast & Opportunities, 2020 discusses the following aspects about the global biochemical sensors market: - Global Biochemical Sensors Market Size, Share & Forecast - Segmental Analysis - By Product Type (Electro-chemical, Thermal, Piezoelectic, Optical, etc.) and By End Use (Medical, Environmental, Nutritional & Agricultural) - Regional Analysis (North America, Europe, Asia-Pacific & Rest of World) - Changing Market Trends & Emerging Opportunities - Competitive Landscape & Strategic Recommendations Market Trends & Developments - Development of Silicon Microsensors - Development of Optical Fibers - Automotive Biochemical Sensors Technology - Growing Demand of Personalized Medicine - Miniaturization of Biochemical sensors - Integration of Wireless Communications Systems - Mass Production of Biochemical sensors Competitive Landscape - Company Shares - Abbott Point of Care Inc - Smiths Medical Md, Inc - LifeSensors Inc - LifeScan Inc. - Medtronic plc - Boston Scientific Corporation - Nova Biomedical Corporation - Acon Laboratories, Inc - Bio-Rad Laboratories, Inc - Universal Biosensors, Inc - Bayer AG - Pharmaco-Kinesis Corporation - SensLab - BioDetection Instruments, Inc - Biosensor Laboratories Incorporated - ABTECH Scientific, Inc - NeuroSky, Inc. - Biosensors International Group, Ltd - Roche Diagnostics - Sysmex Corporation - YSI Life Sciences For more information visit http://www.researchandmarkets.com/research/ctbmsf/global
BSX: 16.88 (+0.09), MDT: 72.60 (+0.55)
Sysmex Inostics Announces Agreement With IndivuTest to Offer Sysmex Inostics Blood Based Mutation Testing in Germany, Austria and Switzerland
PR Newswire Europe - Wed Apr 22, 6:15AM CDT
MUNDELEIN, Illinois and HAMBURG, Germany, April 22, 2015 /PRNewswire/ --
The Urinalysis Systems Market to Reach $1.28 Billion by 2019 - MarketsandMarkets
PRWeb - Sun Apr 19, 7:35PM CDT
The urinalysis market can be broadly divided into biochemical urinalysis and sediment urinalysis. The biochemical urinalysis market is highly fragmented due to presence of few big players and several small players. Prominent players in the biochemical urinalysis market include Siemens Healthcare (Germany), Roche Diagnostics (Switzerland) and Danaher Corporation (U.S.) while the key players in the sediment urinalysis market include Danaher Corporation (U.S.), Sysmex Corporation (Japan) and Urit Medical (China).
DHR: 88.51 (-0.38)
Leading 100 Medical Devices/Technology/Supplies Companies Globally 2015
M2 - Mon Mar 23, 10:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lvb8cp/global_medical) has announced the addition of the "Global Medical Devices/Technology/Supplies 100 - An Industry Report" report to their offering. The global medical device industry has experienced significant growth over the last five years and is expected to continue, reaching approximately US $302 billion in 2017 with a CAGR of 6.1% during the next six years (2011-2017). The global medical industry is one of the world's fastest growing industries, absorbing over 10% of gross domestic product of the most developed nations. It constitutes of broad services offered by various hospitals, physicians, nursing homes, diagnostic laboratories, pharmacies and ably supported by drugs, pharmaceuticals, chemicals, medical equipment, manufacturers and suppliers. With this special industry report, our endeavor is to provide the new investors globally with a complete resourceful research report for familiarizing with the present investment trends in global medical devices/technology/supplies industry, which they would find beneficial to pursue for making business decisions in this sector. Report Highlights: - Leading 100 medical devices/technology/supplies companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical devices/technology/supplies companies - Emerging market International presence of global medical devices/technology/supplies companies - R&D activities in the industry by global medical devices/technology/supplies companies Key Topics Covered: 1: Rankings of Medical Devices/Technology/Supplies Companies Globally 1.1: Leading 100 Medical Devices/Technology/Supplies Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Devices/Technology/Supplies Companies Globally 1.3: Most Profitable 25 Medical Devices/Technology/Supplies Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Devices/Technology/Supplies Companies Globally News Section: 3: Key News of Medical Devices/Technology/Supplies Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Devices/Technology/Supplies Companies Globally 5: International Presence of Global Medical Devices/Technology/Supplies Companies 6: Research and Development Activities in by Global Medical Devices/Technology/Supplies Industry Companies 7: Mergers and Acquisitions in among Global Medical Devices/Technology/Supplies Industry Companies Companies Mentioned (Partial List) - Becton, Dickinson and Company (United States) - Bio Rad Laboratories Incorporated (United States) - Bruker Corporation (United States) - Carl Zeiss Meditec AG (Germany) - Coherent Incorporated (United States) - Coloplast AS (Denmark) - Confident Dental Equipments Limited (India) - Conmed Corporation (United States) - Draegerwerk AG & Co KGaA (Germany) - Gerresheimer AG (Germany) - Illumina, Inc. (United States) - Medcomtech SA (Spain) - Mindray Medical International Limited - adr - ADR (China) - Paul Hartmann AG (Germany) - Shandong Weigao Group Medical Polymer Company Ltd (China) - SHIMADZU CORPORATION (Japan) - St. Jude Medical, Inc. (United States) - Sysmex Corporation (Japan) - Thermo Fisher Scientific Inc. (United States) - Zimmer Holdings, Inc. (United States) For more information visit http://www.researchandmarkets.com/research/lv...al_medical
ZMH: 113.56 (+0.29), STJ: 63.99 (+0.80), ILMN: 147.77 (+7.40), COHR: 57.81 (-0.32), MR: 24.13 (-0.04)
Leading 100 Global Medical Devices Companies 2015
M2 - Mon Mar 23, 10:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/nnxw77/global_medical) has announced the addition of the "Global Medical Devices 100 - An Industry Report" report to their offering. The global medical devices industry will witness significant opportunities for growth in the coming decade. It is predicted that the global medical devices market will reach $398.0bn in 2017 This newly launched report covers various aspects of the global medical devices sector including news, as well as financial/non-financial information and stock market analysis of leading 100 global medical devices companies. There has been an increase in demand for the refurbished medical devices market globally, along with the new equipments market. Until a decade ago, refurbished medical devices were exported to developing countries, and the suppliers involved were not professionally trained, which restrained the growth of this market. However, economic crises and cost containment issues related to healthcare budgets in developed countries like the U.S. and the recent economic recession of Europe has triggered the growth of this market in these countries. Additionally, there has been a surge of trained professionals in this segment. Report Highlights: - Leading 100 medical devices companies globally - Integration of company news and industry news, as well as rankings and stock market performances - Important M&A and alliances among leading global medical devices companies - International presence of global medical devices companies - R&D activities by global medical devices companies Key Topics Covered: 1: Rankings of Medical Devices Companies Globally 1.1: Leading 100 Medical Devices Companies Globally (based on recent sales, net income, total assets, total equity) 1.2: Most Growing 25 Medical Devices Companies Globally 1.3: Most Profitable 25 Medical Devices Companies Globally 2: Stock Market Performance over 5 Years: Leading 25 Medical Devices Companies Globally 3: Key News of Medical Devices Sector Globally for Year 2014 3.1 - Key Company News: By Country and Company 3.2 - Key Company News: By News Category 3.3 - Key Industry News: By News Category 4: Important Alliances among Leading Medical Devices Companies Globally 5: International Presence of Global Medical Devices Companies 6: Research and Development Activities by Global Medical Devices Companies 7: Mergers and Acquisitions among Global Medical Devices Companies Companies Mentioned (Partial List) - Amplifon SpA (Italy) - Bastide le Confort Medical (France) - Digital Optics Co Ltd (South Korea) - Edan Instruments Incorporated (China) - Fujifilm Holdings Corporation (Japan) - Guangzhou Improve Medical Instruments Company Limited (China) - Hitachi High Technologies Corp (Japan) - JVM Co Ltd (South Korea) - Mindray Medical International Limited - adr - ADR (China) - Nan Liu Enterprise Co. Ltd. (Taiwan) - Owens & Minor, Incorporated (United States) - Patterson Companies, Inc. (United States) - Pw Medtech Group Ltd (China) - Suzuken Co (Japan) - Sysmex Corporation (Japan) - Techcomp (Holdings) Ltd. (Singapore) - Teleflex Incorporated (United States) - Terumo Corporation (Japan) - Waters Corporation (United States) - Yamashita Medical Instruments Company Limited (Japan) For more information visit http://www.researchandmarkets.com/research/nn...al_medical
TFX: 125.79 (+0.64), MR: 24.13 (-0.04), WAT: 120.92 (+1.16), OMI: 34.69 (+0.35)
Japanese Healthcare Giant Invests In A Point-Of-Care Coagulation Diagnostic System
Edward Vranic, CFA - at Seeking Alpha - Tue Mar 03, 7:55AM CST
Bio-AMD, Inc. Agreement with Sysmex & General Update
ACCESSWIRE - Tue Jan 27, 7:46AM CST
LONDON, ENGLAND / ACCESSWIRE / January 27, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"
Bio-AMD, Inc.; Agreement with Sysmex and General Update
eTeligis - Tue Jan 27, 7:30AM CST
LONDON, United Kingdom, via ETELIGIS INC., 01/27/2015 - - Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company"
Blood Coagulation Analyzer - 2015 Product Analysis from 17 Blood Coagulation Analyzer Manufacturers
M2 - Fri Jan 23, 9:26PM CST
Research and Markets (http://www.researchandmarkets.com/research/t3r77w/blood_coagulation) has announced the addition of the "Blood Coagulation Analyzer - Product Analysis" report to their offering. This 125 page report "Blood Coagulation Analyzer - Product Analysis" contains 4 figures and 40 Tables provides a comprehensive assessment of the blood coagulation products of the companies. It examines the latest available and emerging coagulation tests and products being utilized by the coagulation testing field and describes the current product lines of almost all of the companies known to be marketing and manufacturing instruments for blood coagulation testing. Each company is discussed in depth with a section on its product line, sales figures and a competitive/comparative tests and product analysis of the company. All the Blood Coagulation Analyzers in the report have been studied from 5 viewpoints: 1. Analyzer Benefits and Features 2. Specifications 3. Net Product Sales 4. Companies - Comparative Tests Analysis 5. Competitive Product Analysis Key Topics Covered: 1. Executive Summary 2. Blood Coagulation Analyzer Companies - Comparative Tests Analysis 3. Blood Coagulation Analyzer - Competitive Product Analysis 4. Alere 5. Siemens Healthcare 6. Sysmex Corporation 7. Coag - Sense 8. Abbott Laboratories Point of Care 9. International Technidyne Corporation 10. Instrumentation Laboratory 11. Roche 12. DiagnosticaStago 13. Tcoag 14. Sekisui Medical Co. Ltd 15. A&T Corporation 16. Prokan 17. Analyticon 18. Sinduri Biotech 19. Helena Laboratories 20. LABiTec GmbH For more information visit http://www.researchandmarkets.com/research/t3...oagulation
ABT: 41.89 (+0.73)